Sign in
4

Changes in Ownership

Milestone Pharmaceuticals Inc. Filed Acc 0001943112-26-000002

Chief Operating Officer sold 70,252 shares at an average $2.25 ($158,209)

  • Chief Operating Officer acquired 100,000 shares (grant or award)
  • Chief Operating Officer acquired 20,100 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Nelson Jeffrey Edward Chief Operating Officer 2025-12-12 Grant or award +100,000 100,000 D
Nelson Jeffrey Edward Chief Operating Officer 2025-12-15 Sale −58,007 $2.32 $134,576 41,993 D
Nelson Jeffrey Edward Chief Operating Officer 2026-01-26 Option exercise +20,100 62,093 D
Nelson Jeffrey Edward Chief Operating Officer 2026-01-26 Sale −12,245 $1.93 $23,633 49,848 D
Derivatives
Nelson Jeffrey Edward Chief Operating Officer 2025-12-12 Grant or award · Employee Stock Option (right to buy) +100,000 100,000 D
Nelson Jeffrey Edward Chief Operating Officer 2026-01-26 Option exercise · Restricted Stock Units −20,100 60,300 D
Open-market sales · 70,252 sh · avg $2.25 · $158,209
Loading xslF345X05/form4-01282026_060107.xml…